Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35202840

In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue.

Manveen K Sethi · Margaret Downs · Chun Shao · William E Hackett · Joanna J Phillips · Joseph Zaia

Molecular & cellular proteomics : MCP · 2022 doi:10.1016/j.mcpro.2022.100216

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35202840
kind
science-record
content_hash
sha256:2cd412cfd3834533cb7cf9c5e840a03b627f268d73c2e86eaf32559a75784c8c
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T17:36:58Z
updated_at
2026-11-01T21:27:18Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue.
doi
10.1016/j.mcpro.2022.100216
pmid
35202840
authors array · 6 items
[0]
Manveen K Sethi
[1]
Margaret Downs
[2]
Chun Shao
[3]
William E Hackett
[4]
Joanna J Phillips
[5]
Joseph Zaia
journal
Molecular & cellular proteomics : MCP
year
2022
abstract
Glioblastoma (GBM) is the most common and malignant primary brain tumor. The extracellular matrix, also known as the matrisome, helps determine glioma invasion, adhesion, and growth. Little attention, however, has been paid to glycosylation of the extracellular matrix components that constitute the majority of glycosylated protein mass and presumed biological properties. To acquire a comprehensive understanding of the biological functions of the matrisome and its components, including proteoglycans (PGs) and glycosaminoglycans (GAGs), in GBM tumorigenesis, and to identify potential biomarker candidates, we studied the alterations of GAGs, including heparan sulfate (HS) and chondroitin sulfate (CS), the core proteins of PGs, and other glycosylated matrisomal proteins in GBM subtypes versus control human brain tissue samples. We scrutinized the proteomics data to acquire in-depth site-specific glycoproteomic profiles of the GBM subtypes that will assist in identifying specific glycosylation changes in GBM. We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples. Several core matrisome proteins, including PGs (decorin, biglycan, agrin, prolargin, glypican-1, and chondroitin sulfate proteoglycan 4), tenascin, fibronectin, hyaluronan link protein 1 and 2, laminins, and collagens, were differentially regulated in GBM versus controls. Interestingly, a higher degree of collagen hydroxyprolination was also observed for GBM versus controls. Further, two PGs, chondroitin sulfate proteoglycan 4 and agrin, were significantly lower, about 6-fold for isocitrate dehydrogenase-mutant, compared to the WT GBM samples. Differential regulation of O-glycopeptides for PGs, including brevican, neurocan, and versican, was observed for GBM subtypes versus controls. Moreover, an increase in levels of glycosyltransferase and glycosidase enzymes was observed for GBM when compared to control samples. We also report distinct protein, peptide, and glycopeptide features for GBM subtypes comparisons. Taken together, our study informs understanding of the alterations to key matrisomal molecules that occur during GBM development. (Data are available via ProteomeXchange with identifier PXD028931, and the peaks project file is available at Zenodo with DOI 10.5281/zenodo.5911810).
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35). The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:35202840
locator
sections[16] "Statistical Analysis and Visualization in RStudio and Microsoft Excel" paragraph 2
quote
For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35).
[1] object · 3 fields
asset
source:pmid:35202840
locator
sections[16] "Statistical Analysis and Visualization in RStudio and Microsoft Excel" paragraph 2
quote
The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35202840
locator
sections[28] "Data Availability" paragraph 2
quote
The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35202840
locator
sections[0] "Abstract" paragraph 1
quote
We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35202840
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD028931
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD028931
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:35202840
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1016/j.mcpro.2022.100216
sha256
sha256:945a67bd7d9cf7a353b7e0f73d57b9c10b4af3b0a2b0cbe649d0d6f5de573cf1
bytes
88752
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1016/j.mcpro.2022.100216
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8957055
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD028931
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD028931
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD028931
version
null
note
The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
In-depth matrisome and glycoproteomic analysis of glioblastoma human brain tissue
resolution_checked_at
2026-11-01T18:06:51Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:PXD028931 not downloaded
[1]
asset:data:geo:PXD028931 licence not read
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
compare means function with a FDR to correct for multiple comparisons; heteroscedastic t test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
reordered
quote
For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35). The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (compare means function with a FDR to correct for multiple comparisons; heteroscedastic t test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD028931
resolved_accessions array · 1 item
[0]
PXD028931
statements array · 1 item
[0]
The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.
basis
The paper names PXD028931 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:35202840
[1]
data:geo:PXD028931
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD028931
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:35:35Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
23830
completion_tokens
1603
cached_tokens
264
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35202840
type
paper
label
pmid:35202840
[1] object · 3 fields
id
source:pmid:35202840
type
manuscript
label
PMID 35202840 full text
[2] object · 3 fields
id
data:geo:PXD028931
type
dataset
label
GEO PXD028931
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35202840
type
paper
label
pmid:35202840
[1] object · 3 fields
id
source:pmid:35202840
type
manuscript
label
PMID 35202840 full text
[2] object · 3 fields
id
data:geo:PXD028931
type
dataset
label
GEO PXD028931
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35202840
type
extraction
used array · 1 item
[0]
source:pmid:35202840
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD028931
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD028931
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35202840
parent_hash
sha256:e6c98eee8b5661893ddde5ba563e9489a7ca20761ea55b1503790b25c993fb54
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:PXD028931 licence not read
[1]
asset:data:geo:PXD028931 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
man brain tissue samples. We scrutinized the proteomics data to acquire in-depth site-specific glyco
[1]
ed on the instrument (for both glycomics and proteomics) at the same time to avoid any sample handli
[2]
d peptide retention time calibration mix for proteomic analysis and disaccharide standards for HS a
[3]
e names and peak database search numbers for proteomics analysis. Detailed information on the cases,
order_basis
paper_text_order:908
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
nd Statistical Rationale In total, 43 tissue microarray (TMA) cores were used; 39 consisted of GBM s
order_basis
paper_text_order:2986
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35202840", "kind": "science-record", "revision": 4, "content_hash": "sha256:2cd412cfd3834533cb7cf9c5e840a03b627f268d73c2e86eaf32559a75784c8c", "created_at": "2026-11-01T17:36:58Z", "updated_at": "2026-11-01T21:27:18Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue.", "doi": "10.1016/j.mcpro.2022.100216", "pmid": "35202840", "authors": ["Manveen K Sethi", "Margaret Downs", "Chun Shao", "William E Hackett", "Joanna J Phillips", "Joseph Zaia"], "journal": "Molecular & cellular proteomics : MCP", "year": 2022, "abstract": "Glioblastoma (GBM) is the most common and malignant primary brain tumor. The extracellular matrix, also known as the matrisome, helps determine glioma invasion, adhesion, and growth. Little attention, however, has been paid to glycosylation of the extracellular matrix components that constitute the majority of glycosylated protein mass and presumed biological properties. To acquire a comprehensive understanding of the biological functions of the matrisome and its components, including proteoglycans (PGs) and glycosaminoglycans (GAGs), in GBM tumorigenesis, and to identify potential biomarker candidates, we studied the alterations of GAGs, including heparan sulfate (HS) and chondroitin sulfate (CS), the core proteins of PGs, and other glycosylated matrisomal proteins in GBM subtypes versus control human brain tissue samples. We scrutinized the proteomics data to acquire in-depth site-specific glycoproteomic profiles of the GBM subtypes that will assist in identifying specific glycosylation changes in GBM. We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples. Several core matrisome proteins, including PGs (decorin, biglycan, agrin, prolargin, glypican-1, and chondroitin sulfate proteoglycan 4), tenascin, fibronectin, hyaluronan link protein 1 and 2, laminins, and collagens, were differentially regulated in GBM versus controls. Interestingly, a higher degree of collagen hydroxyprolination was also observed for GBM versus controls. Further, two PGs, chondroitin sulfate proteoglycan 4 and agrin, were significantly lower, about 6-fold for isocitrate dehydrogenase-mutant, compared to the WT GBM samples. Differential regulation of O-glycopeptides for PGs, including brevican, neurocan, and versican, was observed for GBM subtypes versus controls. Moreover, an increase in levels of glycosyltransferase and glycosidase enzymes was observed for GBM when compared to control samples. We also report distinct protein, peptide, and glycopeptide features for GBM subtypes comparisons. Taken together, our study informs understanding of the alterations to key matrisomal molecules that occur during GBM development. (Data are available via ProteomeXchange with identifier PXD028931, and the peaks project file is available at Zenodo with DOI 10.5281/zenodo.5911810).", "claims": [{"id": "claim-method", "statement": "For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35). The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35202840", "locator": "sections[16] \"Statistical Analysis and Visualization in RStudio and Microsoft Excel\" paragraph 2", "quote": "For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35)."}, {"asset": "source:pmid:35202840", "locator": "sections[16] \"Statistical Analysis and Visualization in RStudio and Microsoft Excel\" paragraph 2", "quote": "The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35202840", "locator": "sections[28] \"Data Availability\" paragraph 2", "quote": "The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810."}], "state": "complete"}, {"id": "claim-target-result", "statement": "We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:35202840", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "We observed an increase in CS 6-O sulfation and a decrease in HS 6-O sulfation, accompanied by an increase in unsulfated CS and HS disaccharides in GBM versus control samples.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35202840"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD028931"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD028931"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35202840", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1016/j.mcpro.2022.100216", "sha256": "sha256:945a67bd7d9cf7a353b7e0f73d57b9c10b4af3b0a2b0cbe649d0d6f5de573cf1", "bytes": 88752, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1016/j.mcpro.2022.100216", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8957055", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD028931", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD028931", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD028931", "version": null, "note": "The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "In-depth matrisome and glycoproteomic analysis of glioblastoma human brain tissue", "resolution_checked_at": "2026-11-01T18:06:51Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD028931 not downloaded", "asset:data:geo:PXD028931 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "compare means function with a FDR to correct for multiple comparisons; heteroscedastic t test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "reordered", "quote": "For statistical analysis, the compare means function was used with a FDR to correct for multiple comparisons (35). The glycomics analysis was performed in Microsoft excel, and p-values were calculated by using heteroscedastic t test, and p-values < 0.05 were considered significant."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (compare means function with a FDR to correct for multiple comparisons; heteroscedastic t test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD028931"], "resolved_accessions": ["PXD028931"], "statements": ["The mass spectral data files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (74, 75) with the dataset identifier PXD028931. The peaks project file is available at Zenodo with 10.5281/zenodo.5911810."], "basis": "The paper names PXD028931 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:35202840", "data:geo:PXD028931"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD028931"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:35:35Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 23830, "completion_tokens": 1603, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35202840", "type": "paper", "label": "pmid:35202840"}, {"id": "source:pmid:35202840", "type": "manuscript", "label": "PMID 35202840 full text"}, {"id": "data:geo:PXD028931", "type": "dataset", "label": "GEO PXD028931"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35202840", "type": "paper", "label": "pmid:35202840"}, {"id": "source:pmid:35202840", "type": "manuscript", "label": "PMID 35202840 full text"}, {"id": "data:geo:PXD028931", "type": "dataset", "label": "GEO PXD028931"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35202840", "type": "extraction", "used": ["source:pmid:35202840"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD028931", "type": "accession_resolution", "used": ["data:geo:PXD028931"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35202840", "parent_hash": "sha256:e6c98eee8b5661893ddde5ba563e9489a7ca20761ea55b1503790b25c993fb54", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:PXD028931 licence not read", "asset:data:geo:PXD028931 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["man brain tissue samples. We scrutinized the proteomics data to acquire in-depth site-specific glyco", "ed on the instrument (for both glycomics and proteomics) at the same time to avoid any sample handli", "d peptide retention time calibration mix for proteomic analysis and disaccharide standards for HS a", "e names and peak database search numbers for proteomics analysis. Detailed information on the cases,"], "order_basis": "paper_text_order:908", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["nd Statistical Rationale In total, 43 tissue microarray (TMA) cores were used; 39 consisted of GBM s"], "order_basis": "paper_text_order:2986", "id": "assay:2"}]}